Pediatrix Medical Group, Inc. (NYSE:MD – Get Free Report) Director Shirley Weis sold 36,028 shares of the business’s stock in a transaction on Wednesday, May 13th. The shares were sold at an average price of $23.75, for a total transaction of $855,665.00. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.
Pediatrix Medical Group Trading Down 4.5%
Shares of NYSE:MD opened at $22.43 on Friday. The stock has a market capitalization of $1.84 billion, a PE ratio of 10.89 and a beta of 0.70. Pediatrix Medical Group, Inc. has a 1 year low of $11.84 and a 1 year high of $24.99. The firm has a fifty day moving average price of $21.54 and a 200 day moving average price of $21.56. The company has a current ratio of 1.33, a quick ratio of 1.33 and a debt-to-equity ratio of 0.45.
Pediatrix Medical Group (NYSE:MD – Get Free Report) last issued its quarterly earnings data on Tuesday, May 5th. The company reported $0.44 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.37 by $0.07. The firm had revenue of $476.20 million during the quarter, compared to analysts’ expectations of $465.83 million. Pediatrix Medical Group had a net margin of 9.02% and a return on equity of 19.94%. Pediatrix Medical Group’s revenue for the quarter was up 3.9% on a year-over-year basis. During the same period in the prior year, the company posted $0.33 earnings per share. Analysts expect that Pediatrix Medical Group, Inc. will post 2.08 EPS for the current fiscal year.
Analysts Set New Price Targets
Get Our Latest Report on Pediatrix Medical Group
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently bought and sold shares of the company. Phocas Financial Corp. lifted its position in Pediatrix Medical Group by 44.5% during the 4th quarter. Phocas Financial Corp. now owns 335,551 shares of the company’s stock worth $7,177,000 after acquiring an additional 103,328 shares during the last quarter. Y Intercept Hong Kong Ltd acquired a new position in Pediatrix Medical Group during the 3rd quarter worth $513,000. Allianz Asset Management GmbH lifted its position in Pediatrix Medical Group by 158.5% during the 3rd quarter. Allianz Asset Management GmbH now owns 158,777 shares of the company’s stock worth $2,660,000 after acquiring an additional 97,365 shares during the last quarter. Dana Investment Advisors Inc. lifted its position in Pediatrix Medical Group by 5.6% during the 3rd quarter. Dana Investment Advisors Inc. now owns 801,462 shares of the company’s stock worth $13,424,000 after acquiring an additional 42,162 shares during the last quarter. Finally, American Century Companies Inc. raised its position in shares of Pediatrix Medical Group by 38.9% during the third quarter. American Century Companies Inc. now owns 2,682,976 shares of the company’s stock valued at $44,940,000 after buying an additional 751,109 shares during the last quarter. Institutional investors and hedge funds own 97.71% of the company’s stock.
About Pediatrix Medical Group
Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.
Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.
Further Reading
- Five stocks we like better than Pediatrix Medical Group
- Viking Sails to All-Time Highs—Fundamentals Signal More to Come
- Datavalut Gains Traction: 5 Reasons to Sell Now
- TMC Stock: Why This Pre-Revenue Miner Is Worth Watching
- The Power Grid Is Dying—Is It Time to Buy Its Replacement?
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
